Home > Financial Ratios > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Standalone]

Mar2025Mar2024Mar2023
   PCE(x) 129.46--

What is the latest Price to Cash Earnings (PCE) ratio of ONESOURCE SPECIALTY PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of ONESOURCE SPECIALTY PHARMA is 129.46 based on Mar2025 Standalone results.
Year Price to Cash Earnings (PCE)
Mar2025129.46
Mar2024-
Mar2023-

How is Price to Cash Earnings (PCE) of ONESOURCE SPECIALTY PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 129.46
0
Mar2024 0
0
Mar2023 0 -

Other Financial Ratios of ONESOURCE SPECIALTY PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹17,361.9 Cr 15.6% 30.3% 11.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.1% 6.2% 13.5% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1% 3.3% 14.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,928.0 Cr -0% 10% 45.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr -0.6% 3.3% 16.4% Stock Analytics
CIPLA ₹107,043.0 Cr -2% -0.6% -6.1% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

15.6%

30.3%

11.7%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses